Baird Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Raises Target Price to $135

Moomoo NewsFeb 14 08:31 ET · Ratings

Morgan Stanley Maintains Blueprint Medicines(BPMC.US) With Hold Rating, Maintains Target Price $120

Moomoo NewsFeb 14 08:31 ET · Ratings

A Quick Look at Today's Ratings for Blueprint Medicines(BPMC.US), With a Forecast Between $125 to $155

Moomoo NewsFeb 14 08:00 ET · Ratings

Express News | Needham Reiterates Buy on Blueprint Medicines, Maintains $133 Price Target

BenzingaFeb 14 07:54 ET

Express News | Blueprint Medicines Corp : Leerink Partners Cuts Target Price to $93 From $98

ReutersFeb 14 07:09 ET

Blueprint Medicines Price Target Maintained With a $135.00/Share by HC Wainwright & Co.

Dow JonesFeb 14 06:41 ET · Ratings